Cargando…
Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study
The titer of live attenuated viral vaccines, such as MMR vaccines, varies between batches and over the shelf-life of a batch, with the highest titer expected at batch release. As higher titers may theoretically lead to increased reactogenicity, we compared the safety profile of an upper-range releas...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343620/ https://www.ncbi.nlm.nih.gov/pubmed/30118386 http://dx.doi.org/10.1080/21645515.2018.1502527 |
Ejemplares similares
-
Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study
por: Ogawa, Taku, et al.
Publicado: (2020) -
Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014) -
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
por: Randi, Bruno Azevedo, et al.
Publicado: (2023) -
2467. Timeliness of Childhood Vaccination With the Combination Measles–Mumps–Rubella–Varicella Vaccine vs. the Separate Measles–Mumps–Rubella and Varicella Vaccines in the United States
por: Wolfson, Lara, et al.
Publicado: (2018) -
Measles-Mumps-Rubella Vaccine and COVID-19 Relationship
por: Özdemir, Öner
Publicado: (2020)